Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Summary

Akoya Biosciences, known as The Spatial Biology Company®, announced its virtual participation in the Morgan Stanley 19th Annual Global Healthcare Conference. The event will feature a fireside chat with CEO Brian McKelligon and CFO Joe Driscoll on September 13, 2021, at 5:00 p.m. ET. A live webcast will be available on Akoya's website for 90 days following the event. Akoya specializes in spatial phenotyping and offers platforms like CODEX® and Phenoptics™ to enhance research in biology and human health.

News Market Reaction – AKYA

-3.74%

-3.74% Session move

In the trading session that priced this news, AKYA declined 3.74%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARLBOROUGH, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

Brian McKelligon, CEO, and Joe Driscoll, CFO, are scheduled to participate in a fireside chat on Monday, September 13^th, 2021 at 5:00 p.m. ET.

A live webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/ and will be available for 90 days thereafter.

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Investor Contact:
David Deuchler
Gilmartin Group LLC
investors@akoyabio.com

Media Contact:
Michelle Linn
Bioscribe, Inc.
774-696-3803
michelle@bioscribe.com

FAQ

When is Akoya's participation in the Morgan Stanley Global Healthcare Conference?

Akoya will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 5:00 p.m. ET.

Who will represent Akoya at the Morgan Stanley conference?

CEO Brian McKelligon and CFO Joe Driscoll will represent Akoya Biosciences at the conference.

How can I watch Akoya's presentation at the conference?

The presentation can be viewed via a live webcast on Akoya's website, available for 90 days after the event.

What products does Akoya Biosciences offer?

Akoya offers CODEX® and Phenoptics™ platforms for spatial phenotyping in biomedical research.

What is the focus of Akoya's research?

Akoya focuses on spatial phenotyping to study biology and human health, emphasizing cell interaction and disease progression.